Hungaropharmaprivatization tender
APV Rt, Hungary's state privatization company, is to invite tenders for the part sale of the drug wholesaler Hungaropharma Rt, which currently controls a third of the domestic market, reports New Europe.
APV will issue an initial public offering for a quarter plus one vote of Hungaropharma to small and institutional domestics and foreign invstors. The second phase will consist of allowing workers, managers and domestic pharmacists to buy a further 25% minus two votes of the wholesaler. Last year, the firm produced a pretax profit of 328 million forint ($1.1 millon).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze